Company News

Cherwell celebrates fortieth birthday UK firm is dedicated to environmental monitoring and validation of sterilisation processes DIA appoints director at DIA India Kaushik Desai takes up the role David Meeker to become ceo of Genzyme Takes the role from 1 November Vanda Pharmaceuticals appoints chief commercial officer Bob Repella joins US biopharmaceutical firm Alan Pilgrim becomes Synexus’ chairman Takes over from Professor Trevor Jones, who will continue as a board director Patheon’s North American president to leave the firm Peter Bigelow to pursue new opportunities from 1 November Quantitech supports Arctic greenhouse gas research Canadian researcher uses DX4015 FTIR analyser to investigate soils in the High Arctic Panmira appoints chief executive Hari Kumar will oversee inflammation portfolio Inspiration Biopharmaceuticals names John Butler as ceo Replaces Michael Griffith who takes position of cso AMRI appoints president of Indian Operations AMRI India md returns to US as director, project management, pharmaceutical services Lundbeck appoints three vps in supply operations and engineering Good examples of talent development at the Danish pharmaceutical firm Steven Skolsky joins Quintiles To head the clinical development leadership team Ronald Scott becomes chief operating officer of Basilea Formerly held role of chief financial officer Eli Lilly announces promotions as senior executives retire Three senior staff will take key executive positions from 1 January 2012 Rx-360 elects new board members They will stand for a three-year term that expires in 2014 Jeans for Genes a good fit for Almac staff Staff are helping to fund research into a wide range of genetic disorders

Trending Articles

  1. New Managing Director for Shimadzu Europa Dr. Florian Geistmann (pictured) takes over as Managing Director of Shimadzu Europa, succeeding Jürgen Semmler, who has retired after five years at the helm of the European organisation and more than 39 years in the company in total
  2. BioDuro appoints Greg Makara to lead discovery chemistry BioDuro has appointed Greg Makara, PhD, as Senior Vice President, Lead Discovery Chemistry, as the contract research, development and manufacturing organisation (CRDMO) looks to strengthen its early-stage drug discovery capabilities.
  3. EyeC expands OEM growth with new business development manager Rigel Gallegos will lead the development of EyeC’s OEM and system integrator business
  4. Three new commercial appointments for Symbiosis Symbiosis Pharmaceutical Services has expanded its commercial team with three new appointments as the specialist aseptic fill-finish CDMO targets further growth across Asia-Pacific, the Middle East and Southern Europe
  5. Lonza nominates Pearl Huang to board Lonza has nominated Pearl Huang as an independent member of its Board of Directors, bringing extensive pharmaceutical and biotechnology experience and expertise in drug discovery and innovation